Risk-sharing alliance on tailor-made phenotypic models for IBD and HBV Upfront payment and milestone payments for MIMETAS Access to know-how on novel disease models and assays for Roche Option to exclusively license of disease models and assays for Roche LEIDEN, The Netherlands — MIMETAS, a leader in organ-on-chip-based disease models and technology, and Roche, a world-leading pharmaceutical […]

SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO) announced significant progress in China with the adoption of its Saphyr® System for optical genome mapping (OGM) by WeHealth Shanghai, a leading provider of genome analysis services in reproductive health. The adoption was announced at the Structural Variation Symposium in Shanghai, organized with support from the Shanghai […]

Chicago/Boston — GE Healthcare and SOPHiA GENETICS today announced that they have signed a letter of intent to collaborate on advancing cancer care, with the goal of better targeting and matching treatments to each patient’s genomic profile and cancer type, helping to ensure the most effective and personalized treatment. The companies aim to develop new artificial intelligence (AI)-powered […]

License agreement to enhance Nippon Gene’s CRISPR/Cas9 research reagents offering Dublin, Ireland and Tokyo, Japan, 01 July 2021: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Nippon Gene Co., Ltd (Nippon Gene), a manufacturer of genetic engineering research reagents and diagnostic reagents […]

Shoreline Biome’s microbiome products now available in the Nordics FARMINGTON, Conn.— Shoreline Biome, a leading microbiome company that develops complete solutions for characterizing microbiome populations down to the strain level, has entered into a partnership with AH diagnostics A/S for product distribution.  Shoreline Biome’s complete suite of products for use on the industry leading next […]

Global strategic alliance to leverage Sysmex’s Plasma-Safe-SeqS technology QIAGEN will use ultra-sensitive liquid biopsy applications in oncology Alliance boosts QIAGEN’s co-development of companion diagnostics with drug makers QIAGEN expects significant benefits for pharma companies and cancer patients worldwide Hilden, Germany, Germantown, Maryland, and Kobe, Japan – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced […]

Leatherhead, UK – Protein Stable and F-star Therapeutics have entered into a collaboration to explore the benefits of the high throughput SUPR-CM platform for early development, lead selection, formulation development and stability prediction. Jon Armer, Formulation Lead Senior Scientist at F-star commented: “At F-star, we are developing next generation tetravalent bispecifics for cancer immunotherapy which […]

Let’s Go Robotics and axiVEND announced today an agreement granting exclusive distribution rights to axiVEND for Precise Drop II and BioRaptr 2.0 products in the US commercial markets. Precise Drop II provides high performance and high precision micro-liquid dispensing at a lower cost. The product is highly configurable, making it easy to use in any environment […]

Co-Marketing Partnership to Expand Reach of Both Companies in the Cannabis and Analytics Space VANCOUVER, BC – Delic Corp (“DELIC” or the “Company“) (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform today announced that its subsidiary, DELIC Labs, has entered into a partnership agreement with Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets. Under the agreement, […]

HELSINKI, Finland —  Euformatics, a bioinformatics software company providing world-leading NGS interpretation and quality control tools has signed a distribution agreement with INSVAST, a company specialising in delivering bioinformatics solutions to Chinese NGS laboratories. The agreement covers the full omnomics Suite of products from Euformatics and provides INSVAST with a full end-to-end offering to their customers […]